(Q35196655)

7 August 2017

1 reference

title

Molecular and genetic prognostic factors of prostate cancer (English)

1 reference

7 August 2017

1 reference

Arnab Chakravarti

1

1 reference

PubMed ID

12910365

7 August 2017

Gary Guotang Zhai

series ordinal

2

1 reference

7 August 2017

9 August 2003

1 reference

7 August 2017

World Journal of Urology

1 reference

7 August 2017

21

1 reference

7 August 2017

4

1 reference

7 August 2017

265-274

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-003-0362-z

7 August 2017

0 references

cites work

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

12 December 2020

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines

1 reference

12 December 2020

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

12 December 2020

Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.

1 reference

12 December 2020

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

1 reference

12 December 2020

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

1 reference

12 December 2020

Comparison of microscopic vascularity in benign and malignant prostate tissue

1 reference

12 December 2020

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

12 December 2020

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer

1 reference

12 December 2020

Changes in cell proliferation and apoptosis during local progression of prostate cancer

1 reference

12 December 2020

Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status

1 reference

12 December 2020

Molecular biologic aspects of human prostatic carcinoma

1 reference

12 December 2020

Topography of neovascularity in human prostate carcinoma

1 reference

12 December 2020

Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x

1 reference

12 December 2020

Bcl-XL and Bcl-2 repress a common pathway of cell death

1 reference

12 December 2020

The role of E-cadherin-catenin complex: more than an intercellular glue?

1 reference

12 December 2020

Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression

1 reference

12 December 2020

Comparison of DNA content in primary and lymph node metastases in prostate adenocarcinoma

1 reference

12 December 2020

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers

1 reference

12 December 2020

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610

1 reference

12 December 2020

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

1 reference

12 December 2020

Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers

1 reference

12 December 2020

A sensitive enzyme immunoassay for human basic fibroblast growth factor

1 reference

12 December 2020

High-throughput microarray technologies: from genomics to clinics

1 reference

12 December 2020

Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma

1 reference

12 December 2020

Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen

1 reference

12 December 2020

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

12 December 2020

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

1 reference

12 December 2020

Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer

1 reference

12 December 2020

Molecular genetics of prostate cancer.

1 reference

12 December 2020

The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

1 reference

12 December 2020

Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?

1 reference

12 December 2020

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry

1 reference

12 December 2020

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

12 December 2020

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

12 December 2020

A potential autocrine role for vascular endothelial growth factor in prostate cancer.

1 reference

12 December 2020

Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis

1 reference

12 December 2020

Serum syndecan-1: a new independent prognostic marker in multiple myeloma

1 reference

12 December 2020

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells

1 reference

12 December 2020

The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy

1 reference

12 December 2020

Oncogenes and tumor suppressor genes in prostate cancer: a review

1 reference

12 December 2020

Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation

1 reference

12 December 2020

Lack of prostate cancer radiosensitization by androgen deprivation

1 reference

12 December 2020

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants

1 reference

12 December 2020

Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulation

1 reference

12 December 2020

Expression of bcl-2 and the progression of human and rodent prostatic cancers

1 reference

12 December 2020

Multiple Bcl-2 family members demonstrate selective dimerizations with Bax

1 reference

12 December 2020

Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients

1 reference

12 December 2020

Bloodborne biomolecular markers in prostate cancer development and progression

1 reference

12 December 2020

Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy.

1 reference

12 December 2020

Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer

1 reference

12 December 2020

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

1 reference

12 December 2020

Emerging molecular markers of cancer.

1 reference

12 December 2020

Androgen receptor gene mutations in human prostate cancer

1 reference

12 December 2020

Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy

1 reference

12 December 2020

Complex cadherin expression in human prostate cancer cells

1 reference

12 December 2020

Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate

1 reference

12 December 2020

Early growth response-1 gene: potential radiation response gene marker in prostate cancer

1 reference

12 December 2020

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

12 December 2020

Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis

1 reference

12 December 2020

Decreased expression of E-cadherin in the progression of rat prostatic cancer

1 reference

12 December 2020

Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas

1 reference

12 December 2020

p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy

1 reference

12 December 2020

Transforming growth factor-beta1 and prostate cancer

1 reference

12 December 2020

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1 reference

12 December 2020

A prognostic value of syndecan-1 in gastric cancer.

1 reference

12 December 2020

Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics.

1 reference

12 December 2020

Endothelins: circulating plasma levels and presence in other biologic fluids

1 reference

12 December 2020

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

12 December 2020

Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis

1 reference

12 December 2020

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma

1 reference

12 December 2020

E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome

1 reference

12 December 2020

Markers of the metastatic phenotype in prostate cancer

1 reference

12 December 2020

Identification of genetic markers for prostatic cancer progression

1 reference

12 December 2020

Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy

1 reference

12 December 2020

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

1 reference

12 December 2020

High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery

1 reference

12 December 2020

Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker

1 reference

12 December 2020

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

12 December 2020

Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

1 reference

12 December 2020

Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer

1 reference

12 December 2020

Morphologic and molecular prognostic markers in prostate cancer

1 reference

12 December 2020

Intestinal cell radiosensitivity: a comparison for cell death assayed by apoptosis or by a loss of clonogenicity.

1 reference

12 December 2020

Endothelin-1 as a target for therapeutic intervention in prostate cancer

1 reference

12 December 2020

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.

1 reference

12 December 2020

Prognostic markers in prostate cancer

1 reference

12 December 2020

Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides

1 reference

12 December 2020

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

1 reference

12 December 2020

Tumors associated with p53 germline mutations: a synopsis of 91 families.

1 reference

12 December 2020

Molecular markers and determinants of prostate cancer metastasis

1 reference

12 December 2020

Cell-cycle dysregulation and the molecular mechanisms of prostate cancer

1 reference

12 December 2020

Syndecan-1 expression has prognostic significance in head and neck carcinoma

1 reference

12 December 2020

Immunohistochemical analysis of cathepsin D in prostate carcinoma

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer

1 reference

12 December 2020

Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone

1 reference

12 December 2020

Low p27 expression predicts poor disease-free survival in patients with prostate cancer

1 reference

12 December 2020

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

1 reference

12 December 2020

Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer

1 reference

12 December 2020

Caveolin-1, a putative tumour suppressor gene

1 reference

12 December 2020

bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer

1 reference

12 December 2020

Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer

1 reference

12 December 2020

Activation of mitogen-activated protein kinase associated with prostate cancer progression.

1 reference

12 December 2020

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas

1 reference

12 December 2020

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

1 reference

12 December 2020

Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer

1 reference

12 December 2020

Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17

1 reference

12 December 2020

Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications

1 reference

12 December 2020

p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy

1 reference

12 December 2020

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

12 December 2020

Hypermethylation of the caveolin-1 gene promoter in prostate cancer

1 reference

12 December 2020

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

12 December 2020

Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma

1 reference

12 December 2020

Chromosomal abnormalities and related events in prostate cancer

1 reference

12 December 2020

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

12 December 2020

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.

1 reference

12 December 2020

A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells

1 reference

12 December 2020

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis

1 reference

12 December 2020

Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype

1 reference

12 December 2020

10.1007/S00345-003-0362-Z

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12910365